Bayer AG NA
I · Analiza AI
Pe scurt
Bayer makes prescription medicines for heart disease, women's health, cancer, and blood disorders; sells consumer brands like Midol and Aspirin; and provides seeds, pesticides, and digital farming tools to agriculture customers worldwide [Yahoo Finance]. The Crop Science division is the largest profit contributor, generating nearly half of total revenue [Simply Wall St].
Bayer is a 161-year-old German life sciences giant operating three major divisions: prescription drugs (Pharmaceuticals), over-the-counter health products (Consumer Health), and agricultural seeds and crop chemicals (Crop Science) [Yahoo Finance]. The company currently reports a €2.2 billion net loss on €45.6 billion in revenue, but recent news signals potential recovery through two FDA priority-review drugs in stroke prevention and lung cancer [Yahoo Finance]. Bayer also faces ongoing environmental liabilities, including a recent $133 million settlement for PCB contamination cleanup [Seeking Alpha].
Bayer is currently unprofitable with moderate debt levels, but maintains strong gross margins and positive free cash flow [Yahoo Finance].
Scor Sentinellis
4.2/10
Moderate concerns
Capitalizare bursieră
EUR 37.8B
Venituri (12 luni)
EUR 45.6B
II · Știri recente
Ce a mișcat prețul
6 stories · ranked by relevance
- macro2026-05-20
BAYRY or RHHBY: Which Is the Better Value Stock Right Now?
Zacks
- macro2026-05-20
Should FDA Priority Review for HYRNUO’s First-Line Lung Cancer Use Require Action From Bayer (XTRA:BAYN) Investors?
Yahoo Finance
- macro2026-05-19
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
Yahoo Finance
- macro2026-05-19
Bayer Granted Priority Review by U.S. FDA for Asundexian in Patients After a Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Yahoo Finance
- macro2026-05-19
FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
Yahoo Finance
- macro2026-05-17
Assessing Bayer (XTRA:BAYN) Valuation After Mixed Share Performance And Profit Recovery Hopes
Simply Wall St
Premium · gratuit cu orice cont
Bayer reported a €2.2 billion net loss for the most recent fiscal year despite €45.6 billion in revenue, and the company remains unprofitable with a negative net margin of -7.9% [Yahoo Finance]
Riscuri
5
Oportunități
5
Semnale de alarmă
3
Conducere
10
Încă 22 de constatări în raportul complet — gratuit cu orice cont.
Deblochează analiza completă Bayer AG NA
Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.
- 5 riscuri, 5 oportunități și 3 semnale de alarmă — fiecare cu sursa lui
- Peste 100 de indicatori financiari, cu grafice și comparații
- Rezumate complete ale știrilor, cu linkuri către surse
- Echipa de conducere și remunerația
- Export PDF pentru citit offline
III · Companii similare
Ai putea citi și
Same sector · Healthcare or comparable health
Vrei compania asta pe lista ta?